Search

Your search keyword '"Cooper-Knock, Johnathan"' showing total 345 results

Search Constraints

Start Over You searched for: Author "Cooper-Knock, Johnathan" Remove constraint Author: "Cooper-Knock, Johnathan"
345 results on '"Cooper-Knock, Johnathan"'

Search Results

2. Rare and common genetic determinants of mitochondrial function determine severity but not risk of amyotrophic lateral sclerosis

3. Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology

4. Deconvolution of polygenic risk score in single cells unravels cellular and molecular heterogeneity of complex human diseases

5. Deep learning modeling of rare noncoding genetic variants in human motor neurons definesCCDC146as a therapeutic target for ALS

6. Whole-genome sequencing reveals that variants in the Interleukin 18 Receptor Accessory Protein 3′UTR protect against ALS

8. Structural variation analysis of 6,500 whole genome sequences in amyotrophic lateral sclerosis

9. Mutations in the tail and rod domains of the neurofilament heavy‐chain gene increase the risk of ALS.

10. TDP-43 is a Master Regulator of Paraspeckle Condensation

11. Characterisation of genotype-phenotype relationships in ALS associated with hexanucleotide repeat expansion of C9orf72

14. TMEM106B is a genetic modifier of frontotemporal lobar degeneration with C9orf72 hexanucleotide repeat expansions.

16. Genome-wide Analyses Identify KIF5A as a Novel ALS Gene

17. Author Correction: Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology

19. A Y374X TDP43 truncation leads to an altered metabolic profile in amyotrophic lateral sclerosis fibroblasts driven by pyruvate and TCA cycle intermediate alterations

22. Large-scale analyses of CAV1 and CAV2 suggest their expression is higher in post-mortem ALS brain tissue and affects survival

23. A cell-penetrant peptide blocking C9ORF72 -repeat RNA nuclear export reduces the neurotoxic effects of dipeptide repeat proteins

25. Chapter Genetics of Familial Amyotrophic Lateral Sclerosis

28. Telomere length analysis in amyotrophic lateral sclerosis using large-scale whole genome sequence data

30. Low expression of EXOSC2 protects against clinical COVID-19 and impedes SARS-CoV-2 replication

32. Clinical testing panels for ALS: global distribution, consistency, and challenges

34. Multiomic analysis reveals cell-type-specific molecular determinants of COVID-19 severity

35. AtypicalTDP‐43 protein expression in anALSpedigree carrying a p.Y374Xtruncation mutation inTARDBP

39. Atypical TDP‐43 protein expression in an ALS pedigree carrying a p.Y374X truncation mutation in TARDBP.

40. Low expression of EXOSC2 protects against clinical COVID-19 and impedes SARS-CoV-2 replication.

43. Unbiased metabolome screen leads to personalized medicine strategy for amyotrophic lateral sclerosis

44. Genome-wide identification of the genetic basis of amyotrophic lateral sclerosis

46. Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology

48. A review of Mendelian randomization in amyotrophic lateral sclerosis

Catalog

Books, media, physical & digital resources